Search

With the birth of genetically engineered twins in November 2018, international debate about human genome editing governance has moved from an emphasis on mutual engagement among multiple stakeholders to a self-regulatory model enacted through high-level expert groups with little or no public input. This article reconstructs this paradigm shift and suggests that inclusive public deliberation should still have a role in public decision making about genome editing. [ABSTRACT FROM AUTHOR]

In this article, the author reports Ethics, Values, and Responsibility in Human Genome Editing. Topics include CRISPR/Cas9 genome editing, an inexpensive and efficient tool to introduce changes in Deoxyribonucleic acid(DNA); include correcting congenital monogenic disorders, targeting disease-causing molecular lesions, and altering multiple genetic loci at the same time; and used to enhance human traits,3 such as resistance to infectious diseases, strength, or cognitive capacity.